5145.0: Wednesday, October 24, 2001 - 2:30 PM

Abstract #31766

Harm reduction products: What, when and for whom

Dorothy Hatsukami, University of Minnesota, , hatsu001@umn.edu

Products and methods for reducing tobacco exposure and/or the harmful toxins of tobacco are being developed or currently being marketed. The consumer and health care provider will be faced with the decision as to whether these product or methods of reduction results in less harm, and whether they should be used among those who are unwilling or unable to quit using tobacco products. This presentation will describe the existing products, which include modified tobacco products or cigarette-like devices, pharmacological products, and other behavioral means for reduction of exposure to tobacco toxicity. The methods used to assess reduction in tobacco toxicity and the pitfalls of these methods will be described. Questions about who should be targeted for tobacco exposure reduction, what measures are necessary from a health care provider’s position to assure that the consumer is not increasing harm and how we measure success will be discussed.

Learning Objectives: See session objectives

Keywords: Tobacco, Tobacco Control

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 129th Annual Meeting of APHA